Similar articles

• Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia.

  Gmür J, Burger J, Schanz U, Fehr J, Schaffner A. Gmür J, et al. Lancet. 1991 Nov 16;338(8777):1223-6. doi: 10.1016/0140-6736(91)92098-m. Lancet. 1991. PMID: 1682642
• Lack of efficacy of prophylactic platelet transfusion for severe thrombocytopenia in adults with acute uncomplicated dengue infection.

  Lye DC, Lee VJ, Sun Y, Leo YS. Lye DC, et al. Clin Infect Dis. 2009 May 1;48(9):1262-5. doi: 10.1086/597773. Clin Infect Dis. 2009. PMID: 19292665
• The platelet prophylactic transfusion trigger: when expectations meet reality.

  Brecher ME. Brecher ME. Transfusion. 2007 Feb;47(2):188-91. doi: 10.1111/j.1537-2995.2007.01121.x. Transfusion. 2007. PMID: 17302761 No abstract available.
• Thrombocytopenia and platelet transfusions in patients with cancer.

  Valent J, Schiffer CA. Valent J, et al. Cancer Treat Res. 2011;157:251-65. doi: 10.1007/978-1-4419-7073-2_15. Cancer Treat Res. 2011. PMID: 21052961 Review.
• [Special features of blood transfusions to hematologic patients].

  Oksanen K. Oksanen K. Duodecim. 1998;114(12):1233-9. Duodecim. 1998. PMID: 11524769 Review. Finnish. No abstract available.